Infectious Diseases News and Research

RSS
UVA scientists make progress in their longstanding efforts to combat tuberculosis

UVA scientists make progress in their longstanding efforts to combat tuberculosis

University of Minnesota receives $66 million to establish new antiviral drug discovery center

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Readiness of the United States to combat known and unknown future infectious pathogens

Readiness of the United States to combat known and unknown future infectious pathogens

Study shows the QuickNavi-COVID19 Ag test has a high diagnostic performance for SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in nasopharyngeal samples

Study shows the QuickNavi-COVID19 Ag test has a high diagnostic performance for SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in nasopharyngeal samples

Research provides new insight into how Crimean-Congo hemorrhagic fever virus causes disease

Research provides new insight into how Crimean-Congo hemorrhagic fever virus causes disease

Five medical organizations release new guidance for preventing hospital-acquired pneumonia

Five medical organizations release new guidance for preventing hospital-acquired pneumonia

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

Researchers discover how one type of T cell creates functionally distinct, but genetically identical daughter cells

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

Expressions of doubt are vital for promoting trust in vaccines, research reveals

Expressions of doubt are vital for promoting trust in vaccines, research reveals

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

New funding boost to combat antibiotic resistance

New funding boost to combat antibiotic resistance

Genetic variants may help explain the variability in COVID-19 severity, study suggests

Genetic variants may help explain the variability in COVID-19 severity, study suggests

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

Study finds Omicron variant is more stable than its ancestral strain on smooth and porous surfaces

Study finds Omicron variant is more stable than its ancestral strain on smooth and porous surfaces

The prevalence of rodent-borne zoonotic viruses in Europe among the small mammals inhabiting farming landscapes

The prevalence of rodent-borne zoonotic viruses in Europe among the small mammals inhabiting farming landscapes

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

Developing innovative approaches to combat urinary tract infections

Developing innovative approaches to combat urinary tract infections

Community-focused model improves equitable access to COVID-19 vaccination

Community-focused model improves equitable access to COVID-19 vaccination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.